The School of Law will host David C. Dvorak, chairman of the board and chief executive officer of DeepThink Health Inc., for a talk Tuesday, Oct. 29, from 4:30 to 5:30 p.m. in the Moot Courtroom.
His talk is titled “Advancing Medicine with Big Data: A Digital Health Company’s Perspective on the Opportunities and Challenges.”
The lecture is free to attend and offers one hour of CLE credit.
About the talk
A variety of scientific and technological advancements are converging to enable significant improvement in the diagnosis and treatment of chronic diseases such as cancer. Artificial intelligence and big data analytics are among the technologies showing great promise in advancing cancer care. By capturing and structuring large clinical, genomic and other datasets, and then applying advanced analytics and machine learning, actionable insights are generated to facilitate the practice of precision medicine and the discovery of new patient treatments. The obvious potential benefits of treating patients in this data-driven manner as opposed to yesterday’s one-size-fits-all solution with trial-and-error approaches are propelling the growth of precision medicine practices. However, several conditions are impacting the pace of adoption of these technologies and practices, including economic, regulatory, legal and ethical factors.
This lecture will examine how health care stakeholders have attempted to balance these complex factors and assess whether the net result of these attempts is consistent with the stated intent to treat patients’ interests as paramount.